| abstract |
The invention relates to compounds of formula (I) in which R is H, halogen, alkyl, hydroxyl, alkoxyl, the radical —COOR, —NRR, —NH — SO — Alk, —NH — CO — Alk, —NR — CO — Alk, -O-Alk-COOR, -O-Alk-NRR, -O- (CH) -Ph, -CO-NRR or -CO-NH-CH (R) - (CH) -COOR; R is H, halogen, cyano, the radical —COOR, —NRR, —NH — SO — Alk, —NH — CO — CF, —NH — CO — Ph, —NH — CO — Alk, —NH — CO — Alk, - CONRR, optionally substituted phenyl or optionally substituted heteroaryl; R and R are independently hydroxyl, alkoxyl, —COOR, nitro, —NRR, —NH — CO — Alk, —NH — CO — Ph, —NH — CO — Alk, —NH — SO — Alk, —CO — NRR or —CO — NHOH or R and R, together with the carbon atoms of the phenyl ring to which they are bonded, form a 6-ring carbon cycle containing a nitrogen atom and another heteroatom such as oxygen; in the form of a base or salt, and also in the form of a hydrate or solvate. The invention relates to a method for producing a pharmaceutical composition and to the use of compounds in various fields of therapy. |